Prostate Cancer News - 2015-10-17
General Case Management
Prostate Cancer Evidence Academy | Penn CMEIf you happen to live in or near to Philadelphia, Pennsylvania, USA, the University of Pennsylvania is organizing a “first of its kind”, all-day Prostate Cancer Evidence Academy meeting in Philadelphia on November 17, 2015. The meeting is open to prostate cancer patients, survivors, and advocates (as well as to healthcare professionals) at very low cost ($15.00) for any who are interested.
When to start planning for end-of-life care and death from prostate cancer | THE "NEW" PROSTATE CANCER INFOLINK
Choices you Make
Patients often too intimidated for a second opinion - NL TimesDoes night-shift work increase the risk of prostate cancer? a systemat | OTT
Exploring the use of aspirin and a diabetes drug for prostate cancer prevention and control | em.gmnews.com | Edison/Metuchen Sentinel
Prostate Cancer Q&A With Key Opinion Leader David F. Penson, MD - Cancer Therapy Advisor
Screening and Diagnosis
Mobile medical service offers prostate screenings - Your West Valley News: PeoriaThe dilemma of screening for prostate cancer | EurekAlert! Science News
Biopsies, Genomics and Pathology
UCLA-led study shows deadly prostate cancer cells have stem cell qualities | UCLAProstate cells undergo 'reprogramming' to form tumors, study finds | EurekAlert! Science News
New technology is taking the guesswork out of diagnosing prostate cancer
Urine biomarkers may reduce repeat biopsies for prostate cancer
Tests
Access : Preoperative low serum testosterone is associated with high-grade prostate cancer and an increased Gleason score upgrading : Prostate Cancer and Prostatic DiseasesBioinformatics tool rapidly verifies prostate cancer biomarkers - Ezine - separationsNOW.com
Treatment
New prostate cancer treatments could target metabolism | EurekAlert! Science NewsSide Effects
Access : Metabolic abnormalities linked to an increased cardiovascular risk are associated with high-grade prostate cancer: a single biopsy cohort analysis : Prostate Cancer and Prostatic DiseasesED Induced by Prostate Biopsy Likely 'Underestimated'
Advanced/Recurrence
Radionuclides Provide Pain Relief for Prostate Cancer Bone Mets | Cancer NetworkProstate cancer: Wnt signalling induces resistance : Nature Reviews Urology : Nature Publishing Group
Aggressive prostate cancer risk not higher with testosterone therapy - UPI.com
Aspen Park Pharmaceuticals licenses late-stage prostate cancer drug developed by Ohio State, partners - Columbus - Columbus Business First
Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2015 by ReportBazzar | Medgadget Medgadget
No comments:
Post a Comment